Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

Source : Thailand Medical News  Feb 19, 2020  4 years, 6 days, 6 hours, 54 minutes ago

New Study Shows That Vitamin E Can Treat Non-alcoholic Steatohepatitis (NASH) In HIV Patients

New Study Shows That Vitamin E Can Treat Non-alcoholic Steatohepatitis (NASH) In HIV Patients
Source : Thailand Medical News  Feb 19, 2020  4 years, 6 days, 6 hours, 54 minutes ago
Non-alcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver inflammation and cell damage. It is a potentially dangerous condition that can progress to cirrhosis or liver cancer. Unfortunately, HIV patients tend to have a high prevalence of the disease.

A new study by McGill University, Canada has found that Vitamin E can be effective in treating the condition in HIV patients.
The study's lead author Dr. Giada Sebastiani, Associate Professor in the Department of Medicine, McGill University and bioresearcher at the Research Institute of the McGill University Health Centre told Thailand Medical News ,"Vitamin E has been shown to improve fatty liver in the general population. Here we provide evidence for its beneficial effect and safety in people living with HIV, who have a higher prevalence of fatty liver disease."
The research findings have been published in the study appears in the February issue of the journal AIDS.
NAFLD currently affects up to 48% of Canadians living with HIV and 25% of the general population, while NASH affects about one third of patients with NAFLD. Global figures are almost similar.
A few theories exist to explain the high prevalence of fatty liver among HIV-positive patients.
Dr Sebastiani added, "It is possibly due to HIV-related inflammation, the antiretroviral drugs that they have to take lifelong, and to very frequent metabolic problems, such as diabetes and high lipids. Unfortunately, there is no approved therapy for fatty liver in people living with HIV."
For the research, 27 patients with HIV and NASH were given vitamin E in an easily-tolerated dose of two pills per day.
Dr Sebastiani further added, "We found that vitamin E improved both liver transaminases (the main blood tests for liver function) and liver fat measured by a non-invasive ultrasonographic test. These improvements were even more marked than those reported in the HIV-uninfected population."
The vitamin E significantly reduced inflammation and fat in the HIV-positive patients in a very sizeable way.
The author noted that because the study did not have the benefit of a control group, and the study group was small and had a short follow-up (24 weeks), it's considered a pilot project.
& nbsp;
Dr Sebastiani added, "We would be interested in conducting a larger randomized controlled trial, with a longer follow-up.”
Reference: Vitamin E is an effective treatment for non-alcoholic steatohepatitis in HIV mono-infected patients," by G. Sebastiani, P. Ghali, M. Klein, et al, was published February 1, 2020 ,journal AIDS.
DOI: 10.1097/QAD.0000000000002412


Jun 10, 2023  9 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19